Cell Therapy Developer Moving to Woodlands Facility

Cellipont Bioservices is leaving its 26,000 square foot San Diego location for a newer and larger one in the Woodlands. They are moving into a 76,000 commercial-ready manufacturing facility which is expected to be ready for occupancy in early 2023. Houston-based LEAD Construction is doing the work on the facility in phases.

Cellipont’s Deborah Wild is looking forward to the move, “As our client programs advance through the clinic and toward commercialization, we are working diligently to offer them state-of-the art facilities and capabilities. This site near Houston is an ideal location to serve clients and patients across all of North America, with two major airports and a strong local workforce.”

The facility will include manufacturing, process development, assay development and testing capabilities.

The JLL Capital Markets Investment Advisory team representing the tenant was led by Directors Dave Baker and Brian Buglione and Managing Director Kevin McConn.